RecruitingPhase 1Phase 2NCT06836206

The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi

The Effect of Gum Arabic (GA) on Adult Dialysis Patients in Abu Dhabi: A Prospective Randomized-controlled Trial (The GADAD Study)

Sponsor

Abu Dhabi Health Services Company

Enrollment

40 participants

Start Date

Feb 3, 2025

Study Type

INTERVENTIONAL

Conditions

End Stage Renal Disease (ESRD)

Summary

Gum Arabic (GA), derived from Acacia trees, has shown potential benefits in metabolic, renal, and inflammatory conditions. This study explores the impact of GA on residual renal function in end-stage renal disease (ESRD) patients undergoing dialysis, as current evidence is limited.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial tests whether gum arabic — a natural dietary fiber from acacia trees — can help preserve remaining kidney function in dialysis patients. Even a small amount of residual kidney function in people on dialysis has major health benefits. **You may be eligible if...** - You are 18 or older and have end-stage kidney disease (ESRD) - You are on regular dialysis (at least once a week, for at least 2 weeks) - You still produce some urine — at least 200 mL per day - You are using contraception or have completed childbearing (for women of childbearing age) **You may NOT be eligible if...** - You produce no urine at all (no residual kidney function) - You are pregnant or unwilling to use contraception - You have other significant health conditions that the study team determines would interfere Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.